K-877

Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)

Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal Function

Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment

Study to Assess the Food Effect of K-877 in Healthy Adult Volunteers

A Study of Pemafibrate in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)

Pharmacokinetic Drug-Drug Interaction Study Between K-877 and CSG452 in Healthy Adult Volunteers

Drug-Drug Interaction Study to Assess the Effects of Multi Dose Clopidogrel on the Pharmacokinetics of Single-Dose K-877 in Healthy Adult Volunteers

Drug-Drug Interaction Study to Assess the Effects of Multiple-Dose Administration of K-877 on the Pharmacodynamics and the Pharmacokinetics of Multiple-Dose Administration of Warfarin in Healthy Adult Volunteers

Drug-Drug Interaction Study in Healthy Adult Volunteers

Drug-Drug Interaction Study in Healthy Adult Volunteers

Drug-Drug Interaction Study in Healthy Adult Volunteers

Drug-Drug Interaction Study in Healthy Adult Volunteers

Drug-Drug Interaction Study in Health Adult Volunteers